GO
Loading...

California

More

  • MIAMI, March 5- A $5 million class-action lawsuit filed this week in Florida accuses hardwood and laminate flooring giant Lumber Liquidators, Inc of selling products laden with cancer-causing chemicals. Senator Bill Nelson of Florida, the ranking Democrat on the Senate Committee on Commerce, Science and Transportation, called on federal agencies Wednesday...

  • Avalanche Biotech reports 4Q loss Thursday, 5 Mar 2015 | 10:10 AM ET

    MENLO PARK, Calif. _ Avalanche Biotechnologies Inc. on Thursday reported a loss of $10.4 million in its fourth quarter. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 33 cents per share. This story was generated by Automated Insights using data from Zacks Investment Research.

  • March 5- Kroger Co, the biggest U.S. supermarket operator, forecast a full-year profit above analysts' estimates as it benefits from its acquisition of Harris Teeter Supermarkets Inc and higher margins on fuel. Kroger shares rose 6.7 percent to a record high of $74.30 in morning trading on Thursday. Kroger completed its $2.5 billion acquisition of Harris Teeter...

  • Supermarket operator Kroger's profit rises 23 pct Thursday, 5 Mar 2015 | 8:53 AM ET

    March 5- Kroger Co, the biggest U.S. supermarket operator, on Thursday reported a 23 percent rise in quarterly profit, helped by its acquisition of Harris Teeter Supermarkets Inc and higher margins on fuel. Net income attributable to Kroger rose to $518 million, or $1.04 per share, in the fourth quarter ended Jan. 31, from $422 million, or 81 cents per share, a year...

  • Ares Management misses 4Q profit forecasts Thursday, 5 Mar 2015 | 8:33 AM ET

    LOS ANGELES _ Ares Management LP on Thursday reported fourth-quarter profit of $3.2 million. The average estimate of six analysts surveyed by Zacks Investment Research was for earnings of 36 cents per share. Ares Management shares have increased 19 percent since the beginning of the year.

  • Ringling Bros. to give up elephant acts in 3 years Thursday, 5 Mar 2015 | 8:06 AM ET

    The move announced Thursday is bittersweet and didn't come easily, Feld family members said as they broke the news to The Associated Press. "It was a decision 145 years in the making," said Juliette Feld, who now helps run the circus company with her sisters and father, Feld Enterprises Inc. President Kenneth Feld. "We're not reacting to our critics; we're creating the...

  • Arrowhead buys Novartis' RNAi portfolio Thursday, 5 Mar 2015 | 7:34 AM ET

    March 5- Arrowhead Research Corp said it acquired Novartis AG's RNAi assets to fortify its position in the field of gene therapy that aims to wipe out disease-causing proteins. Novartis is eligible to receive $25 million in Arrowhead shares within 30 days, which would make it the second-largest shareholder based on Arrowhead's market value on Wednesday.

  • NEW YORK, March 5- Exchange-traded funds designed to let investors play China's bond markets, which are mostly closed to foreigners, are facing a slow start amid concerns about mainland issuers' credit quality, high property prices and the slowing economy. At more than $5 trillion, China's onshore fixed-income markets are outranked only by the U.S. and Japanese...

  • Dynavax Technologies reports 4Q loss Thursday, 5 Mar 2015 | 6:48 AM ET

    BERKELEY, Calif. _ Dynavax Technologies Corp. on Thursday reported a loss of $22.3 million in its fourth quarter. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of $1.06 per share. Dynavax Technologies shares have climbed 26 percent since the beginning of the year.

  • The growth target of about 7 percent, down from last year's 7.5 percent, is in line with efforts to create a "moderately prosperous society," said Premier Li Keqiang in a report Thursday to China's ceremonial national legislature. It is trying to replace a worn-out model driven by trade and investment in construction and heavy industry that has left China's air...

  • BEIJING, March 5- China's transport minister said on Thursday he hopes to have regulations issued on using mobile apps to book private cars within the first half of 2015, state media reported, amid doubts on the legal status in China of Uber and similar services. In January, China's Ministry of Transport banned taxi hailing apps such as Uber Technologies Inc and...

  • SAN FRANCISCO— Zully Broussard thought she was going to help one person by donating a kidney. The Sacramento woman's donation to a Benicia man set off an organ swap that resulted in five more sick people getting new kidneys at a San Francisco hospital. With a total of a dozen patients and donors, this week's surgeries at the California Pacific Medical Center...

  • Jury hears closing arguments in 'Blurred Lines' case Thursday, 5 Mar 2015 | 4:14 AM ET

    LOS ANGELES— Marvin Gaye was part of the soundtrack of Pharrell Williams' life growing up, and the Grammy-winning singer-producer told a jury that he did not borrow from his idol's work to craft the 2013 hit "Blurred Lines." Testimony in the case will conclude on Thursday after jurors hear from rapper T.I., who was added to the song after Williams and singer Robin...

  • SAN FRANCISCO— A sex discrimination trial against one of Silicon Valley's most prestigious venture capital firms is providing a rare peek into the elite investment companies vying to fund the next Google and Amazon. Their partnership rosters are stacked with some of the nation's most accomplished graduates— multiple-degree holders from schools such as...

  • March 5- AbbVie Inc is to buy Pharmacyclics Inc for about $21 billion, giving it access to what is expected to be one of the world's top-selling cancer drugs and expanding its reach in the profitable oncology field. AbbVie will pay $261.25 per share in cash and stock, a 13 percent premium to Pharmacyclics stock's closing price on Wednesday. Deutsche Bank analyst...

  • *AbbVie to pay $261.25 per share in cash and stock. The deal gives AbbVie access to Pharmacyclics' cancer drugs portfolio, lessening the Chicago- based company's dependence on its rheumatoid arthritis drug Humira that accounts for most of its sales. "Imbruvica is not only complementary to AbbVie's oncology pipeline, it has demonstrated strong clinical...

  • AbbVie will spend about $21 billion to buy fellow drugmaker Pharmacyclics and add another major revenue producer to a portfolio that already includes the world's top-selling drug. AbbVie executives told analysts on Thursday that their company could reap more than $7 million in annual sales from Imbruvica in a few years. While AbbVie touted the potential...

  • LOS ANGELES, March 4- A second top Los Angeles hospital has reported an outbreak of drug-resistant "superbug" infections, and dozens more potential exposures, from procedures performed with a fiber-optic instrument called a duodenoscope. The Cedars-Sinai cases, like the larger number of infections and potential exposures reported last month at the UCLA...

  • SAN FRANCISCO— Microsoft is attempting to break down the walls surrounding console gaming. Phil Spencer, head of the company's video game division, detailed Microsoft's plan for game makers to create universal apps that can run on both Xbox One consoles and PCs with Windows 10, as well as smartphones, tablets and other devices running the forthcoming version...

  • March 4- A plan by McDonald's Corp to phase out chicken raised with certain kinds of antibiotics at its 14,000 U.S. restaurants will put additional pressure on an already-stressed supply chain. Available product has been so tight that when six of the largest U.S. school districts tried to make the switch to antibiotic-free poultry last year, chicken sellers...